OpGen is a medical devices business based in the US. OpGen shares (OPGN) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $1.83 – a decrease of 6.15% over the previous week.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.83 |
|---|---|
| 52-week range | $1.61 - $13.40 |
| 50-day moving average | $2.16 |
| 200-day moving average | $3.70 |
| Wall St. target price | $3.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-40.32 |
Historical closes compared with the close of $1.83 from 2024-10-11
| 1 week (2024-10-08) | -6.15% |
|---|---|
| 1 month (2024-09-13) | -18.30% |
| 3 months (2024-07-15) | -40.20% |
| 6 months (2024-04-15) | 178.12% |
| 1 year (2023-10-13) | 122.63% |
|---|---|
| 2 years (2022-10-14) | 863.16% |
| 3 years (2021-10-15) | 2.03 |
| 5 years (2019-10-15) | 6.2 |
| Revenue TTM | $2 million |
|---|---|
| Gross profit TTM | $-8,990,133 |
| Return on assets TTM | -43.25% |
| Return on equity TTM | -314.92% |
| Profit margin | 0% |
| Book value | $-8.65 |
| Market Capitalization | $16.5 million |
TTM: trailing 12 months
We're not expecting OpGen to pay a dividend over the next 12 months.
OpGen's shares were split on a 1:10 basis on 19 May 2024. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OpGen shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for OpGen shares which in turn could have impacted OpGen's share price.
Over the last 12 months, OpGen's shares have ranged in value from as little as $1.61 up to $13.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while OpGen's is -0.656. This would suggest that OpGen's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, OpGen has bucked the trend.
OpGen, Inc. , a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland. .
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
What you need to know about investing in the leading indicator for the overall US stock market.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.